Recent News
Pharma Companies Face DOJ Scrutiny After Zantac Recalls
GlaxoSmithKline and Sanofi SA are facing more scrutiny over recent Zantac recalls. According to separate filings with the U.S. Securities and Exchange Commission (SEC), federal prosecutors are trying to determine if the companies violated the federal False Claims Act by … Continue reading
Firefighter Foam Lawsuits Mount, as Filings Exceed 800 in Federal Multidistrict Litigation
The consolidated litigation established for all federally filed lawsuits involving aqueous film-forming foams (AFFF) continues to move forward in the U.S. District Court, District of South Carolina, where more than 800 cases have been filed on behalf of firefighters and … Continue reading
FDA Announces Campaign to Publicize Allergan Breast Implant Recall
The U.S. Food & Drug Administration (FDA) has announced a new campaign to better publicize a recent recall for certain Allergan textured breast implants due to their association with a rare form of lymphoma. Allergan Aesthetics’ multi-channel campaign will include … Continue reading
Zantac Lawsuits Move Forward, as Federal Litigation Convenes Initial Conference
The federal litigation established earlier this year for Zantac cancer lawsuits finally convened an Initial Conference last month, following a delay necessitated by the global coronavirus pandemic. The conference took place over a period of two days, May 12th and … Continue reading
California Appeals Court Set to Hear Oral Arguments in First Monsanto Roundup Verdict
A California appeals court will hear oral arguments tomorrow in Bayer AG’s bid to dismiss the massive verdict awarded to the plaintiff at the conclusion of the nation’s first Monsanto Roundup trial. About the Monsanto Roundup Appeal The hearing before … Continue reading
FDA Seeks Metformin Recalls after Tests Confirm NDMA Contamination
Bernstein Liebhard is not currently pursuing lawsuits on this drug, but if you fill out our form, we will let you know if that changes. The U.S. Food & Drug Administration (FDA) has asked five pharmaceutical companies to recall certain … Continue reading
Atrium Hernia Mesh Litigation Grows, as Federal MDL Exceeds 2,100 Filings
Hernia mesh lawsuits involving Atrium Medical Corp.’s C-Qur mesh continue to mount in the federal multidistrict litigation now underway in the U.S. District Court, District of New Hampshire. According the New Hampshire Business Review, 2,136 claims were pending in the … Continue reading
Metformin Lawsuit News: FDA Finds High Levels of Cancer-Causing Chemical in Popular Diabetes Drugs
Bernstein Liebhard is not currently pursuing lawsuits on this drug, but if you fill out our form, we will let you know if that changes. Mere months after reassuring the public that metformin was safe, the U.S. Food & Drug … Continue reading
Ethicon Physiomesh News: Federal Court Reschedules Hernia Mesh Lawsuit Trials
Thousands of hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Composite Flexible mesh continue to move forward in the U.S. District Court, Northern District of Georgia, where the first bellwether trial is now scheduled to get underway this coming November. Ethicon … Continue reading
Zantac Lawsuit Court Sets Deadlines for Initial Census
The Zantac litigation currently underway in the U.S. District Court, Southern District of Florida, continues to move forward, following the issuance of an order establishing deadlines for the proceeding’s Initial Census. Zantac Lawsuits Undergoing 2-Phase Initial Census There are currently … Continue reading
Follow Us
